has subject area Antirheumatic Agents Arthritis, Rheumatoid Clinical Trials as Topic Drug Therapy, Combination Humans Observational Studies as Topic Randomized Controlled Trials as Topic Recurrence Treatment Outcome Tumor Necrosis Factor Inhibitors
Keywords anti–tumor necrosis factor discontinuation rheumatoid arthritis rheumatoid arthritis remission
